Matthew Neal MD: Clinical Trials

4 trials sponsored by Matthew Neal MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 1 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Terminated 1
Phase 31Terminated 1
Phase 41Completed 1

Follow Matthew Neal MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer
Blue light, Amber light, Ambient White Light - Pancreatic Neoplasms, Rectal Neoplasms
Not applicableTerminatedMatthew Neal MD22022-08-142024-05-21
Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
theraputic heparin, prophylactic heparin, P2Y12 - Covid19
Phase 4CompletedMatthew Neal MD35912020-09-042024-12-30
REMAP Trial for Optimizing Surgical Outcomes at UPMC
Metformin ER, Placebo - Aging
Phase 3TerminatedMatthew Neal MD3022019-04-152024-06-18
Utilization of TEG to Monitor Rivaroxaban Activity
blood sampling - Anemia, Venous Thrombosis
CompletedMatthew Neal MD1002016-04-012019-11-08

Conditions studied

Anemia (1)  ·  COVID-19 (1)  ·  Pancreatic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Venous Thrombosis (1)

Interventions

Blood Specimen Collection (1)  ·  Canagliflozin (1)  ·  Clopidogrel (1)  ·  Dalteparin (1)  ·  Enoxaparin (1)  ·  Heparin (1)  ·  Metformin (1)  ·  Prasugrel Hydrochloride (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  Ticagrelor (1)  ·  Tinzaparin (1)  ·  crizanlizumab (1)  ·  dapagliflozin (1)  ·  empagliflozin (1)  ·  ertugliflozin (1)

Countries

United States (4)  ·  Brazil (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Jeffrey Berger, MD (1)  ·  Judith Hochman, MD (1)  ·  Matthew D Neal, MD (1)  ·  Matthew D Neal, MD, FACS (1)  ·  Matthew Neal, MD (1)  ·  Mikhail Kosiborod, MD (1)  ·  Scott Solomon, MD (1)

Results publications

PMID 32994242, PMID 33502773, PMID 34473343, PMID 36942550, PMID 37227729, PMID 37356038, PMID 37489818, PMID 37979717, PMID 39250922, PMID 42089155

NIH funding

1OT2HL156812-01 (1)